Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Endoscopy|October 31, 2007
A new stapler-based full-thickness transgastric access closure: results from an animal pilot trialP Magno, S A Giday, X Dray, et al.
Alimentary Pharmacology & Therapeutics|October 22, 2013
Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitisV S Akshintala, S M Hutfless, E Colantuoni, et al.
Gastrointestinal Endoscopy|November 26, 1999
Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trialsG M Eisen, E A Montgomery, N Azumi, et al.
Gastrointestinal Endoscopy|January 1, 1991
Utility of upper endoscopy in the evaluation of noncardiac chest painP C Hsia, K A Maher, J H Lewis, et al.
Archives of Internal Medicine|September 1, 1987
Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalitiesD A Johnson, W E Drane, J Curran, et al.
The American Journal of Clinical Nutrition|July 1, 1995
Dietary fat modulates gastric lipase activity in healthy humansM Armand, M Hamosh, J S DiPalma, et al.
Surgical Endoscopy|January 25, 2006
Transgastric endoscopic splenectomy: is it possible?S V Kantsevoy, B Hu, S B Jagannath, et al.
The American Journal of Medicine|March 1, 1990
Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteriesR O Cannon, E L Cattau, P N Yakshe, et al.
Archives of Internal Medicine|March 1, 1989
Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?D A Johnson, W E Drane, J Curran, et al.
The American Journal of Gastroenterology|February 24, 2001
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safetyD A Johnson, S B Benjamin, N B Vakil, et al.
Pageof 13